Drug allergy to CFTR modulator therapy associated with lumacaftor-specific CD4+ T lymphocytes - 04/02/21
Doi : 10.1016/j.jaci.2020.05.041
Jobst F. Roehmel, MD a, ∗, Monday O. Ogese, PhD b, ∗, Alexander Rohrbach, MSc a, Marcus A. Mall, MD a, c, d, ‡, Dean J. Naisbitt, PhD b, ‡ 
a Department of Pediatric Pulmonology, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany
b Department of Molecular and Clinical Pharmacology, MRC Centre for Drug Safety Science, University of Liverpool, Liverpool, United Kingdom
c Berlin Institute of Health (BIH), Berlin, Germany
d German Center for Lung Research (DZL), Berlin, Germany
| This study was funded in part by a grant from the German Cystic Fibrosis Association Mukoviszidose e.V. (grant no. 1705). M.O. is a postdoctoral researcher funded by the Biotechnology and Biological Sciences Research Council (BBSRC, grant no. BB/R008108/1). M.A.M. has been supported by grants from the German Federal Ministry of Education and Research (grant no. 82DZL004A1) and the Einstein Foundation Berlin (grant no. EP-2017-393). |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflict of interest. |
© 2020
American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 147 - N° 2
P. 753-756 - Febbraio 2021 Ritorno al numero
Articolo precedente
- Plasma C3d levels as a diagnostic marker for complete complement factor I deficiency
- Leslie Naesens, Julie Smet, Simon J. Tavernier, Petra Schelstraete, Levi Hoste, Stijn Lambrecht, Helene Verhelst, Jutte van der Werff ten Bosch, Alina Ferster, Sophie Blumental, Pascale Hilbert, Tessa Kerre, Johan Vande Walle, Christoph Licht, Lubka T. Roumenina, Patrick Stordeur, Filomeen Haerynck
- TH cell diversity and response to dupilumab in patients with atopic dermatitis
- Coline Trichot, Lilith Faucheux, Léa Karpf, Maximilien Grandclaudon, Lucia Pattarini, Martine Bagot, Thibault Mahévas, Marie Jachiet, Anne Saussine, Jean-David Bouaziz, Vassili Soumelis
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?